Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 352-356, January 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamazaki, M.
Right arrow Articles by Okutomi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, M.
Right arrow Articles by Okutomi, T.

Augmentation of Release of Cytotoxin from Murine Bone Marrow and Peritoneal Macrophages by Tumor Transplantation1

Masatoshi Yamazaki2 and Takafumi Okutomi

Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko, Tsukui-gun, Kanagawa 199-01, Japan

Cytotoxin release by bone marrow-adherent cells and peritoneal macrophages was transiently augmented by i.p. inoculation of syngeneic tumor cells, but not normal cells. These effects were maximal 24–48 h after tumor transplantation. The cytotoxin released from bone marrow-adherent cells obtained 24 h after tumor inoculation had a molecular weight of about 70,000. Peritoneal macrophages obtained 24 h after tumor inoculation released mainly a cytotoxin with a molecular weight of about 55,000, whereas 48-h peritoneal macrophages released both Mr 55,000 and 70,000 cytotoxins. Activities of these three cytotoxins were inhibited by the addition of rabbit anti-murine tumor necrosis factor antibody. No change in expression of antigens on cells producing the cytotoxin was detected in bone marrow-adherent cells obtained 24 h after tumor inoculation, compared to normal bone marrow-adherent cells. However, expression of surface antigens of peritoneal macrophages obtained 24 h after tumor inoculation differed from that of peritoneal macrophages obtained 48 h later. Antigen expression of 48-h peritoneal macrophages producing the cytotoxin was similar to that of 24-h bone marrow-adherent cells producing the cytotoxin. Taken together with the cytotoxin data, it appears that some cells in 48-h peritoneal macrophages may originate from 24-h bone marrow macrophages. These data suggest that the local tumor burden stimulates the central macrophages in bone marrow as well as the local macrophages and that stimulated macrophages in bone marrow may then mobilize to the local site of the tumor transplantation.

1 Supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture of Japan.

2 To whom requests for reprints should be addressed.

Received 4/ 4/88. Revised 7/28/88. Revised 10/13/88. Accepted 10/19/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.